inadequate drug delivery to the brain , caused by an intact or partially intact blood-brain barrier ( bbb ) , probably accounts for poor therapeutic responsiveness to cytoreductive drugs by malignant metastatic and primary brain tumors .
C0006104
brain
C0750974
primary brain tumors